| Literature DB >> 23863604 |
Chao Niu1, Dong Yu, Yuelan Wang, Hongguang Ren, Yuan Jin, Wei Zhou, Beiping Li, Yiyong Cheng, Junjie Yue, Zhixian Gao, Long Liang.
Abstract
In the process of host-pathogen interactions, bacterial pathogens always employ some special genes, e.g., virulence factors (VFs) to interact with host and cause damage or diseases to host. A number of VFs have been identified in bacterial pathogens that confer upon bacterial pathogens the ability to cause various types of damage or diseases. However, it has been clarified that some of the identified VFs are also encoded in the genomes of nonpathogenic bacteria, and this finding gives rise to considerable controversy about the definition of virulence factor. Here 1988 virulence factors of 51 sequenced pathogenic bacterial genomes from the virulence factor database (VFDB) were collected, and an orthologous comparison to a non-pathogenic bacteria protein database was conducted using the reciprocal-best-BLAST-hits approach. Six hundred and twenty pathogen-specific VFs and 1368 common VFs (present in both pathogens and nonpathogens) were identified, which account for 31.19% and 68.81% of the total VFs, respectively. The distribution of pathogen-specific VFs and common VFs in pathogenicity islands (PAIs) was systematically investigated, and pathogen-specific VFs were more likely to be located in PAIs than common VFs. The function of the two classes of VFs were also analyzed and compared in depth. Our results indicated that most but not all T3SS proteins are pathogen-specific. T3SS effector proteins tended to be distributed in pathogen-specific VFs, whereas T3SS translocation proteins, apparatus proteins, and chaperones were inclined to be distributed in common VFs. We also observed that exotoxins were located in both pathogen-specific and common VFs. In addition, the architecture of the two classes of VFs was compared, and the results indicated that common VFs had a higher domain number and lower domain coverage value, revealed that common VFs tend to be more complex and less compact proteins.Entities:
Keywords: bacterial pathogens; common virulence factor; pathogen-specific virulence factor
Mesh:
Substances:
Year: 2013 PMID: 23863604 PMCID: PMC5359729 DOI: 10.4161/viru.25730
Source DB: PubMed Journal: Virulence ISSN: 2150-5594 Impact factor: 5.882
Table 1. Distributions of the VFs from the VFDB inside vs. outside of PAIs
| In PAIs | Outside of PAIs | SUM | |
|---|---|---|---|
| Pathogen-specific VFs | 361 | 259 | 620 |
| Common VFs | 474 | 894 | 1368 |
| SUM | 835 | 1153 | 1988 |
Pearson Chi-square test with Yates continuity correction. χ-squared = 96.3863, df = 1, P < 2.2e−16.
Table 2. The distribution of pathogen-specific and common VFs in each functional category according to the VFDB classification
| VFDB classification | Pathogen-specific | Common | |||
|---|---|---|---|---|---|
| # | %a | # | %a | ||
| Functional categories with a higher percentage of pathogen-specific VFs | |||||
| Exotoxin | 73 | 11.77 | 37 | 2.70 | 1.49e−14* |
| Type IV secretion system (T4SS) | 76 | 12.26 | 56 | 4.09 | 4.01e−10* |
| Unclassified protein (T3SS)c | 90 | 14.52 | 99 | 7.24 | 9.84e−06* |
| Effector protein (T3SS) | 31 | 5.00 | 18 | 1.32 | 1.41e−05* |
| Pathogenicity islandd | 171 | 27.58 | 267 | 19.52 | 3.34e−04* |
| Antiphagocytosis-associated protein | 4 | 0.65 | 1 | 0.07 | 1.24e−01 |
| Chaperone(T3SS) | 8 | 1.29 | 7 | 0.51 | 2.58e−01 |
| Protease | 7 | 1.13 | 7 | 0.51 | 3.85e−01 |
| Type VII secretion system | 14 | 2.26 | 18 | 1.32 | 4.30e−01 |
| Plasminogen activator | 2 | 0.32 | 1 | 0.07 | 4.92e−01 |
| Translocation protein (T3SS) | 5 | 0.81 | 5 | 0.37 | 6.16e−01 |
| Anti-proteolysis | 1 | 0.16 | 0 | 0.00 | 6.11e−01 |
| Afimbrial adhesin | 28 | 4.52 | 49 | 3.58 | 6.68e−01 |
| Actin-based motility | 1 | 0.16 | 1 | 0.07 | 8.60e−01 |
| Proinflammatory effect | 1 | 0.16 | 1 | 0.07 | 8.32e−01 |
| Exoenzyme | 12 | 1.94 | 22 | 1.61 | 1 |
| Secretion apparatus protein(T3SS) | 12 | 1.94 | 25 | 1.83 | 1 |
| Categories with a higher percentage of common VFs | |||||
| Flagella | 1 | 0.16 | 146 | 10.67 | 1.08e−14* |
| Capsule | 11 | 1.77 | 122 | 8.92 | 7.70e−08* |
| Endotoxin or lipopolysaccharide(LPS) | 4 | 0.65 | 70 | 5.12 | 5.50e−07* |
| Iron uptake | 9 | 1.45 | 88 | 6.43 | 1.90e−05* |
| Regulation | 0 | 0.00 | 33 | 2.41 | 2.62e−05* |
| Type VI secretion system(T6SS) | 1 | 0.16 | 37 | 2.70 | 1.01e−04* |
| Type II secretion system(T2SS) | 2 | 0.32 | 30 | 2.19 | 6.24e−03* |
| Stress protein | 0 | 0.00 | 12 | 0.88 | 8.71e−02 |
| Cell metabolism | 0 | 0.00 | 9 | 0.66 | 2.11e−01 |
| Unclassified | 6 | 0.97 | 30 | 2.19 | 2.64e−01 |
| Urease | 0 | 0.00 | 7 | 0.51 | 2.90e−01 |
| Immune evasion | 1 | 0.16 | 10 | 0.73 | 4.42e−01 |
| Cell wall | 1 | 0.16 | 10 | 0.73 | 4.22e−01 |
| Biofilm formation | 0 | 0.00 | 4 | 0.29 | 5.97e−01 |
| Intracellular survival | 0 | 0.00 | 4 | 0.29 | 5.75e−01 |
| Invasion | 3 | 0.48 | 13 | 0.95 | 7.05e−01 |
| Magnesium uptake | 0 | 0.00 | 3 | 0.22 | 8.52e−01 |
| IgA1 protease | 0 | 0.00 | 3 | 0.22 | 8.26e−01 |
| Serum resistance | 0 | 0.00 | 3 | 0.22 | 8.02e−01 |
| Fimbriae | 44 | 7.10 | 103 | 7.53 | 1 |
| Molecular mimicry | 1 | 0.16 | 3 | 0.22 | 1 |
| Manganese uptake | 0 | 0.00 | 1 | 0.07 | 1 |
| Complement protease | 0 | 0.00 | 2 | 0.15 | 1 |
| Nutrient acquisition | 0 | 0.00 | 1 | 0.07 | 1 |
| Biosurfacant | 0 | 0.00 | 2 | 0.15 | 1 |
| Peptidase | 0 | 0.00 | 1 | 0.07 | 1 |
| Enzyme | 0 | 0.00 | 1 | 0.07 | 1 |
| Heat-shock protein | 0 | 0.00 | 1 | 0.07 | 1 |
| Pigment | 0 | 0.00 | 2 | 0.15 | 1 |
| Bile resistance | 0 | 0.00 | 1 | 0.07 | 1 |
| Complement resistance | 0 | 0.00 | 1 | 0.07 | 1 |
| Resistance to antimicrobial peptides | 0 | 0.00 | 1 | 0.07 | 1 |
| SUM | 620 | 1368 | |||
a The percentage of pathogen-specific or common VFs in a given functional category. bPearson Chi-square test with Yates continuity correction (see Materials and Methods). Asterisks indicate statistical significance (P value < 0.05). cThe number of the genes involved with T3SS, except for the number of effector proteins, chaperones, translocation apparatus proteins and secretion apparatus proteins included in the T3SS. dThe number of the genes involved in PAIs, not including the number of the virulence factors included in other functional categories, e.g., the number of the genes encoding T3SS or T4SS in PAIs.
Table 3. Proportions of pathogen-specific exotoxins from the VFDB according to the VFDB classification
| Exotoxin | Subclassification | Total | Pathogen-specific exotoxins | ||
|---|---|---|---|---|---|
| # | # | %a | |||
| Membrane-acting | Superantigen | 19 | 19 | 100 | |
| Enterotoxin | 3 | 3 | 100 | ||
| Membrane-damaging | Pore-forming | - | 4 | 4 | 100 |
| Channel-forming involving | 1 | 1 | 100 | ||
| Channel-forming involving | 7 | 7 | 100 | ||
| Cholesterol-dependent cytolysin (CDC) | 4 | 4 | 100 | ||
| RTX toxin | 14 | 0 | 0 | ||
| Phospholipase C | 7 | 1 | 14.29 | ||
| Intracellular toxin | Adenylate cyclase | 4 | 3 | 75 | |
| ADP-ribosyltransferase | 26 | 18 | 69.23 | ||
| DnaseI | 3 | 2 | 66.67 | ||
| Neurotoxin | 2 | 2 | 100 | ||
| N-glycosidase | 6 | 6 | 100 | ||
| Deamidase | 2 | 0 | 0 | ||
| Glucosyltransferase | 1 | 0 | 0 | ||
| Other toxins | Murine toxin | 1 | 1 | 100 | |
| Hemolysin/bacteriocin: Biofilm formation | 4 | 2 | 50 | ||
| Accessory cholera enterotoxin | 1 | 0 | 0 | ||
| Zona occludens toxin | 1 | 0 | 0 | ||
| SUM | 110 | 73 | |||
a The percentage of pathogen-specific exotoxins in a given functional category.
Table 4. T4SSs of four well-studied pathogenic bacteria and their proportions of pathogen-specific effectors
| Bacterium | T4SS | SUMa | Pathogen-specific effector proteins | References | |
|---|---|---|---|---|---|
| # | # | %b | |||
| VirB/VirD4 | 7 | 4 | 57.14 | ||
| Ptl | 5 | 5 | 100 | ||
| 1 | 1 | 100 | |||
| Dot/lcm | 18 | 16 | 88.89 | ||
| SUM | 31 | 26 | 83.87 | ||
a The number of all known effectors in a given bacterium. bThe percentage of pathogen-specific effectors in a given bacterium.
Table 5. The characteristics and functions of each functional category that was more inclined to be found in common VFs
| Functional categories | Characteristics | Functions | References |
|---|---|---|---|
| Flagella | Surface organelle | Flagella are used for motility and chemotaxis in bacteria | |
| Capsule | Primarily structural component of gram-positive cell wall | Protect and avoid phagocytosis | |
| Lipopolysaccharide (LPS) or endotoxin | Components of the outer membrane of the cell wall of gram-negative bacteria | Activate the host complement pathway | |
| Iron uptake | Mediate the release of host iron for parasitic consumption | Used for iron uptake and heme-utilization | |
| Regulation | Regulate the expression of various genes | Adapt to the host surrounding | |
| Type VI secretion system | T6SSs are widespread in gram-negative proteobacteria | A secretory system that play a general role in mediating host interaction | |
| Type II secretion system | T2SSs are encoded by genes of the general secretion pathway (gsp) and are widely distributed in gram-negative bacteria | Main terminal branch of the general secretory pathway |

Figure 1. The proportion of multi-domain proteins among the VF proteins.
Table 6. Distributions of the VFs from the VFDB in single-domain vs. in multi-domain proteins
| Proteins with one annotated domain | Proteins with two or more annotated domains | SUM | |
|---|---|---|---|
| Pathogen-specific VFs | 318 | 104 | 422 |
| Common VFs | 760 | 540 | 1300 |
| SUM | 1078 | 644 | 1722 |
Pearson Chi-square test with Yates continuity correction. χ-squared = 38.1187, df = 1, P value = 6.657e−10.

Figure 2. The DC of common and pathogen-specific VF proteins.